Earlier this month, the Center for Medicare and Medicaid Services (CMS) announced it will only cover the cost of aducanumab—a new Alzheimer’s disease (AD) drug that I’ve talked about here [...]
Earlier this month, the Center for Medicare and Medicaid Services (CMS) announced it will only cover the cost of aducanumab—a new Alzheimer’s disease (AD) drug that I’ve talked about here [...]